Unmet Needs and Their Impact on Quality of Life and Symptoms in Myelodysplastic Neoplasm Patients and Caregivers
Authors:
- Elena CrisàECElena Crisà
- Daniela CilloniDCDaniela Cilloni
- Marta RivaMRMarta Riva
- Enrico BalleariEBEnrico Balleari
- Daniela BarracoDBDaniela Barraco
- Beatrice ManghisiBMBeatrice Manghisi
- Lorenza BorinLBLorenza Borin
- Michela CalmasiniMCMichela Calmasini
- Anna CalvisiACAnna Calvisi
- Isabella CapodannoICIsabella Capodanno
- Matteo Giovanni Della PortaMPMatteo Giovanni Della Porta
- Elisa DiralEDElisa Diral
Preprint
- 31 March 2025
- preprint
- Published by MDPI AG in Preprints.org
Abstract
Background/Objectives: This study aimed to assess the unmet needs of myelodysplas-tic neoplasm (MDS) patients and their caregivers, focusing on how these needs impact quality of life (QoL) and daily functioning. MDS predominantly affects older adults. It is often complicated by severe red blood cell transfusion-dependent anemia and may require frequent hospital visits, conferring a substantial burden on patients and care-givers. Methods: A national survey was conducted between June 2022 and May 2023 in 46 hematology centers in Italy, involving 259 patients and 105 caregivers. The sur-vey included validated QoL tools (QOL-E and HM-PRO) to measure the impact of dis-ease and treatments on health-related (QoL) and symptoms. Results: Of the patients surveyed, 42% were transfusion-dependent, with 45% reporting distress related to hospital travel, which was significantly associated with lower QoL scores (QOL-E physical score 50.0 vs. 62.5, p<0.001). Transfusion dependency led to worse outcomes across physical, emotional, and social domains (HM-PRO part A score 59.8 vs 23.7, p<0.001). Anxiety affected 66% of patients, while 56% reported feeling emotionally distressed. Forty-eight percent of patients required a caregiver, and among the care-givers, 29% reported significant disruptions in their work, including job changes or reduced hours. Patients requiring frequent hospital visits showed notably worse QoL scores (HM-PRO emotional score 56.8 vs. 31.8, p<0.001). Conclusions: The study iden-tified substantial unmet needs for MDS patients, particularly in addressing the heavy burden of transfusions and hospital visits. Both patients and caregivers experienced significant impact on daily life and in QoL, underscoring the urgent need for treat-ments that reduce hospital dependency, improve patient outcomes, and alleviate the caregiver burden.Keywords
All Related Versions
This publication has 35 references indexed in Scilit:
- Real-world impact of luspatercept on red blood cell transfusions among patients with myelodysplastic syndromes: A United States healthcare claims database studyLeukemia Research, 2024
- Real-World Study of the Burden of Myelodysplastic Syndromes in Patients and Their Caregivers in Europe and the United StatesOncology and Therapy, 2024
- Experiences and Support Needs of Caregivers of Patients with Higher-Risk Myelodysplastic Syndrome via Online Bulletin Board in the USA, Canada and UKOncology and Therapy, 2023
- Targeting health-related quality of life in patients with myelodysplastic syndromes – Current knowledge and lessons to be learnedBlood Reviews, 2021
- Anemia-Induced Bleeding in Patients with Platelet DisordersTransfusion Medicine Reviews, 2021
- Chronic fatigue in myelodysplastic syndromes: Looking beyond anemiaCritical Reviews in Oncology/Hematology, 2020
- New Approaches for Anemia in MDSClinical Lymphoma Myeloma and Leukemia, 2020
- Fatigue, symptom burden, and health‐related quality of life in patients with myelodysplastic syndrome, aplastic anemia, and paroxysmal nocturnal hemoglobinuriaCancer Medicine, 2019
- The Impact of Myelodysplastic Syndromes on Quality of Life: Lessons Learned from 70 VoicesJournal of Supportive Oncology, 2012
- A mathematical model for the evaluation of amplitude of hemoglobin fluctuations in elderly anemic patients affected by myelodysplastic syndromes: correlation with quality of life and fatigueLeukemia Research, 2007